Response to the report published by the UK House of Commons All-Party Parliamentary Group on Chronic Fatigue Syndrome/Myalgic Encephalitis (CFS/ME): implications for cardiometabolic risk
No abstract available (Source: Cardiovascular Endocrinology)
Source: Cardiovascular Endocrinology - November 17, 2022 Category: Cardiology Tags: Correspondence Source Type: research

National level prescribing of psychotropic medication in primary care during the COVID-19 pandemic in England: potential implications for cardiometabolic health
No abstract available (Source: Cardiovascular Endocrinology)
Source: Cardiovascular Endocrinology - November 17, 2022 Category: Cardiology Tags: Correspondence Source Type: research

Cardiac autonomic neuropathy linked to left ventricular dysfunction in type 1 diabetic patients
Conclusion HRV indices notably LF/HF ratio seem to be an early and sensitive predictor of DCM, the latter finding not only underlines the role of microvascular injury in the induction of DCM but might help also for the early detection and reversal of it. (Source: Cardiovascular Endocrinology)
Source: Cardiovascular Endocrinology - November 17, 2022 Category: Cardiology Tags: Original article Source Type: research

Enhancing type 2 diabetes treatment through digital plans of care. First results from the East Cheshire Study of an App to support people in the management of type 2 diabetes
Conclusion These preliminary findings point to how the provision of personalised plans of care, support and education linked to a mobile app, can result in HbA1c and BMI reduction over a 6-month period. While the results are preliminary, they portend the potential for digital plans of care to enhance T2DM management. (Source: Cardiovascular Endocrinology)
Source: Cardiovascular Endocrinology - August 18, 2022 Category: Cardiology Tags: Short report Source Type: research

Preexisting atrial fibrillation and myocardial infarction: only 10% of infarcts directly linked to atrial fibrillation
The aim of the study was to evaluate the incidence and prognosis of type 1 myocardial infarction (T1MI) and type 2 MI (T2MI) in patients with acute MI and known atrial fibrillation (AF) to identify MI directly linked to AF. Among the 669 patients, four patients with hyperthyroidism were excluded, and among the remaining 665 patients, about two-thirds were diagnosed with T1MI, and the remaining third were diagnosed with T2MI. AF was the direct cause of MI in 9.8% of our overall population [1.8% of T1MI type C (coronary embolism), 4.9% of T2MI type A and 3.1% of T2MI type B]. Among patients with T2MI, 30-day mortality was lo...
Source: Cardiovascular Endocrinology - August 18, 2022 Category: Cardiology Tags: Short report Source Type: research

Can glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors help in mitigating the risk of atrial fibrillation in patients with diabetes?
The role of glucagon-like peptide-1 receptor agonists (GLP-1 RA) and dipeptidyl peptidase-4 inhibitors (DPP-4i) in mitigating the risk of atrial fibrillation (AF) remains unknown. We interrogated the Food and Drug Administration’s Adverse Event Reporting System (FAERS) database to study the association between AF-related adverse events and the use of GLP-1 RA and DPP-4i. A signal of disproportionate reporting of AF was detected with the DPP-4i group compared with all the other drugs in the FAERS database [ROR, 2.56; 95% confidence interval (CI), 2.10–3.12], whereas there was no disproportionality signal detected with t...
Source: Cardiovascular Endocrinology - August 18, 2022 Category: Cardiology Tags: Short report Source Type: research

A retrospective real-world observational pilot analysis of Waya: a self-monitoring fitness app in Germany
Conclusion The results from our pilot study showed that Waya is beneficial in bringing about short-term weight loss mainly through behavioral changes in nutrition. Although physical activity levels improved, its influence on weight loss was not apparent. (Source: Cardiovascular Endocrinology)
Source: Cardiovascular Endocrinology - August 18, 2022 Category: Cardiology Tags: Original article Source Type: research

Glucose dysregulation and repolarization variability markers are short-term mortality predictors in decompensated heart failure
Objective As recently reported, elevated fasting glucose plasma level constitutes a risk factor for 30-day total mortality in acutely decompensated chronic heart failure (CHF). Aim of this study was to evaluate the 30-day mortality risk in decompensated CHF patients by fasting glucose plasma level and some repolarization ECG markers. Method A total of 164 decompensated CHF patients (M/F: 94/71; mean age, 83 ± 10 years) were studied; Tend (Te), QT interval (QT) and 5 min of ECG recordings were obtained, studying mean, SD and normalized index of the abovementioned ECG intervals. These repolarization variables and...
Source: Cardiovascular Endocrinology - August 18, 2022 Category: Cardiology Tags: Original article Source Type: research

Living with diabetes and its impact on mental health: results of an online survey
No abstract available (Source: Cardiovascular Endocrinology)
Source: Cardiovascular Endocrinology - May 22, 2022 Category: Cardiology Tags: Correspondence Source Type: research

A survey of physician experience and treatment satisfaction prescribing once-weekly semaglutide injections for patients with type 2 diabetes in Canada
We assessed physicians’ experiences of prescribing once-weekly (OW) semaglutide to patients with type 2 diabetes (T2D) in Canada. Physicians who had prescribed OW semaglutide to ≥2 patients with T2D in the past 12 months and had been doing so for ≥3 months were surveyed during 1–17 October 2018. Prescribing reasons, treatment satisfaction and reasons for discontinuation were assessed. Of the 50 participants, 72% and 54% were prescribed OW semaglutide due to its superior glycemic control and effect on weight, respectively. Most physicians were more satisfied with injection frequency (62%), effect on weight (60%), ac...
Source: Cardiovascular Endocrinology - May 22, 2022 Category: Cardiology Tags: Short report Source Type: research

Naltrexone alters cardiovascular function following acute forced swimming in mice
Purpose Naltrexone (NTX) is an opioid antagonist that can reverse the physiological effects of opioid receptors when bound. Opioid receptors have been found to play a role in cardiovascular (CV) function, and thus, binding of NTX may alter CV activity at rest and in response to acute and chronic exercise (EX). We hypothesized that opioid receptor blockade will alter the typical CV responses following acute EX. Methods We assessed the effects of opioid receptor blockade on CV function via echocardiography in mice following an acute bout of forced swimming (FSw), a model of rodent EX. We administered opioid recept...
Source: Cardiovascular Endocrinology - May 22, 2022 Category: Cardiology Tags: Original article Source Type: research

Reducing fatigue-related symptoms in Long COVID-19: a preliminary report of a lymphatic drainage intervention
Conclusion Our findings suggest that a specific manual lymphatic drainage intervention may help to reduce fatigue symptoms related to Long COVID, perhaps preventing acute symptoms through early intervention. (Source: Cardiovascular Endocrinology)
Source: Cardiovascular Endocrinology - May 22, 2022 Category: Cardiology Tags: Original article Source Type: research

Actiste diabetes management as a service innovation – impact on everyday life – Swedish patients experience assessed by validated MedTech20 questionnaire
No abstract available (Source: Cardiovascular Endocrinology)
Source: Cardiovascular Endocrinology - February 18, 2022 Category: Cardiology Tags: Correspondence Source Type: research

Application of a city wide digital population database for outcome analysis in diabetes: SARS-CoV-2, diabetes and hospital admission rate month by month in Greater Manchester, UK
No abstract available (Source: Cardiovascular Endocrinology)
Source: Cardiovascular Endocrinology - February 18, 2022 Category: Cardiology Tags: Correspondence Source Type: research

SARS-CoV-2, diabetes and mortality: month by month variation in mortality rate from June 2020 to June 2021
No abstract available (Source: Cardiovascular Endocrinology)
Source: Cardiovascular Endocrinology - February 18, 2022 Category: Cardiology Tags: Correspondence Source Type: research